VNDANasdaq United States
Market cap
$300.678 M
$5.00 -2.25%
Close of 7 Aug 2026
Revenue
$216.1M
#2270 by revenue
Earnings
-$220.5M
Loss-making
Shares outstanding
60,462,687
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Vanda Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.